Literature DB >> 27493313

Treatment strategies for acute metabolic disorders in neonates.

Sarar Mohamed1.   

Abstract

Acute metabolic emergencies in neonates represent a challenge to the medical and nursing staff. If not treated optimally, these disorders are associated with poor outcome. Early diagnosis, supportive therapy and specific measures addressing the derranged metabolic process are the gold standards for favorable results. This review highlights treatment strategies for Inborn Errors of Metabolism (IEM) presenting in the neonatal period.

Entities:  

Keywords:  Inborn errors; Metabolism; Neonate

Year:  2011        PMID： 27493313      PMCID： PMC4949838     

Source DB:  PubMed          Journal:  Sudan J Paediatr        ISSN： 0256-4408


  51 in total

1.  Glycogen storage disease type I: diagnosis, management, clinical course and outcome. Results of the European Study on Glycogen Storage Disease Type I (ESGSD I).

Authors:  Jan Peter Rake; Gepke Visser; Philippe Labrune; James V Leonard; Kurt Ullrich; G Peter A Smit
Journal:  Eur J Pediatr       Date:  2002-08-22       Impact factor: 3.183

2.  Effect of continuous glucose therapy with uncooked cornstarch on the long-term clinical course of type 1a glycogen storage disease.

Authors:  David A Weinstein; Joseph I Wolfsdorf
Journal:  Eur J Pediatr       Date:  2002-07-31       Impact factor: 3.183

3.  The tandem mass spectrometry newborn screening experience in North Carolina: 1997-2005.

Authors:  D M Frazier; D S Millington; S E McCandless; D D Koeberl; S D Weavil; S H Chaing; J Muenzer
Journal:  J Inherit Metab Dis       Date:  2006-02       Impact factor: 4.982

4.  Pharmacological rescue of carnitine transport in primary carnitine deficiency.

Authors:  Cristina Amat di San Filippo; Marzia Pasquali; Nicola Longo
Journal:  Hum Mutat       Date:  2006-06       Impact factor: 4.878

5.  Cardiomyopathy and carnitine deficiency.

Authors:  Cristina Amat di San Filippo; Matthew R G Taylor; Luisa Mestroni; Lorenzo D Botto; Nicola Longo
Journal:  Mol Genet Metab       Date:  2008-03-11       Impact factor: 4.797

Review 6.  Pompe's disease.

Authors:  Ans T van der Ploeg; Arnold J J Reuser
Journal:  Lancet       Date:  2008-10-11       Impact factor: 79.321

7.  Survival after treatment with phenylacetate and benzoate for urea-cycle disorders.

Authors:  Gregory M Enns; Susan A Berry; Gerard T Berry; William J Rhead; Saul W Brusilow; Ada Hamosh
Journal:  N Engl J Med       Date:  2007-05-31       Impact factor: 91.245

8.  Decline of acute encephalopathic crises in children with glutaryl-CoA dehydrogenase deficiency identified by newborn screening in Germany.

Authors:  Stefan Kölker; Sven F Garbade; Nikolas Boy; Esther M Maier; Thomas Meissner; Chris Mühlhausen; Julia B Hennermann; Thomas Lücke; Johannes Häberle; Jochen Baumkötter; Wolfram Haller; Edith Muller; Johannes Zschocke; Peter Burgard; Georg F Hoffmann
Journal:  Pediatr Res       Date:  2007-09       Impact factor: 3.756

Review 9.  Inborn errors of metabolism: part 1: overview.

Authors:  Paul A Levy
Journal:  Pediatr Rev       Date:  2009-04

10.  The impact of screening for propionic and methylmalonic acidaemia.

Authors:  James V Leonard; Suresh Vijayaraghavan; John H Walter
Journal:  Eur J Pediatr       Date:  2003-10-30       Impact factor: 3.183
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.